Dr Verslas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 925,485 | 1,581,069 | 327,066 | 119,992 | 789,290 | 2,468,509 | 5,191,096 | 4,698,169 |
| Profit before tax | 54,035 | 50,974 | 12,214 | -381 | 30,584 | 330,824 | 1,062,186 | 11,432 |
| Net profit | 44,687 | 42,003 | 10,071 | -383 | 24,968 | 280,334 | 902,617 | 8,567 |
| Equity | 88,230 | 130,233 | 140,304 | 139,921 | 164,889 | 445,223 | 1,347,839 | 1,356,405 |
| Liabilities | 237,271 | 167,115 | 126,513 | 124,680 | 204,089 | 495,213 | 614,068 | 810,580 |
| Non-current assets | 4,784 | 172,384 | 192,362 | 200,505 | 215,810 | 526,359 | 908,736 | 991,161 |
| Current assets | 320,717 | 124,727 | 73,293 | 63,850 | 172,879 | 411,097 | 1,051,332 | 1,168,550 |
| Total assets | 325,501 | 297,111 | 265,655 | 264,355 | 388,689 | 937,456 | 1,960,068 | 2,159,711 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 108,866 | - | - |
| Social insurance contributions | - | - | - | - | - | 125,815 | 207,159 | 309,439 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +70.5% | +70.8% | -79.3% | -63.3% | +557.8% | +212.8% | +110.3% | -9.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 13.7% | 14.1% | 3.8% | -0.1% | 6.4% | 29.9% | 46.1% | 0.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 50.6% | 32.3% | 7.2% | -0.3% | 15.1% | 63.0% | 67.0% | 0.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.8% | 2.7% | 3.1% | -0.3% | 3.2% | 11.4% | 17.4% | 0.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.8% | 3.2% | 3.7% | -0.3% | 3.9% | 13.4% | 20.5% | 0.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.7 | 1.3 | 0.9 | 0.9 | 1.2 | 1.1 | 0.5 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 47,259 | 163,558 | 50,971 | 25,261 | 31,054 | 51,427 | 74,872 | 53,037 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dr Verslas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-18 | 2026-05-18 | 8027.29 |
| 2026-05-17 | 2026-05-17 | 26027.29 |
| 2026-03-27 | 2026-03-27 | 25656.62 |
| 2026-03-17 | 2026-03-18 | 25656.62 |
| 2026-02-18 | 2026-02-22 | 23303.97 |
| 2025-07-16 | 2025-07-23 | 21051.15 |
| 2023-02-17 | 2023-02-21 | 6579.96 |
| 2022-07-25 | 2022-08-11 | 7.03 |
| 2022-06-16 | 2022-06-19 | 129.73 |
| 2022-05-17 | 2022-05-17 | 7099.32 |
Dr Verslas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-10-08 | 2025-10-16 | 48011.17 |
| 2025-09-19 | 2025-09-25 | 12098.95 |
| 2025-09-17 | 2025-09-18 | 12042.62 |
| 2025-08-22 | 2025-08-22 | 36934.32 |
| 2025-08-21 | 2025-08-21 | 36924.84 |
| 2025-08-19 | 2025-08-20 | 58767.25 |
| 2025-08-15 | 2025-08-18 | 58818.52 |
| 2025-07-31 | 2025-08-14 | 78549.86 |
| 2025-07-30 | 2025-07-30 | 78549.54 |
| 2025-07-25 | 2025-07-29 | 78549.86 |
| 2025-07-24 | 2025-07-24 | 88929.64 |
| 2025-07-20 | 2025-07-23 | 88915.74 |
| 2025-07-18 | 2025-07-19 | 88912.96 |
| 2025-07-17 | 2025-07-17 | 89155.99 |
| 2025-07-16 | 2025-07-16 | 80525.34 |
| 2025-07-10 | 2025-07-15 | 87869.73 |
| 2025-07-04 | 2025-07-09 | 97719.67 |
| 2025-06-30 | 2025-07-03 | 92857.05 |
| 2025-06-27 | 2025-06-29 | 92996.86 |
| 2025-06-26 | 2025-06-26 | 135488.37 |
| 2025-06-25 | 2025-06-25 | 135451.88 |
| 2025-06-22 | 2025-06-24 | 135305.92 |
| 2025-06-21 | 2025-06-21 | 135269.43 |
| 2025-06-20 | 2025-06-20 | 145422.94 |
| 2025-06-19 | 2025-06-19 | 145383.71 |
| 2025-06-18 | 2025-06-18 | 10142.55 |
| 2025-04-30 | 2025-04-30 | 21000.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dr Verslas, UAB (code 302417821) is a Private Limited Liability Company active in new construction. In financial year 2025, the company generated revenue of €4.70M, down 9.5% year on year from €5.19M in 2024, but still well above €2.47M in 2023. Profitability weakened sharply in 2025: net profit fell to €8.6K from €902.6K a year earlier, indicating a near break-even result after two stronger years. The 2023–2024 period showed rapid growth, with revenue almost doubling and net profit rising from €280.3K to €902.6K. The balance sheet expanded further in 2025, with total assets increasing to €2.16M, equity at €1.36M and liabilities at €810.6K. The equity ratio remained strong at 62.8%, and debt to equity was 0.60, suggesting a moderate leverage position. Asset turnover was 2.18x, showing efficient use of assets in revenue generation. Revenue per employee was €53.4K, while profit per employee was minimal because of the very low 2025 profit.